MBOT Long Call Strategy

MBOT (Microbot Medical Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.

Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications. Additionally, Microbot Medical maintains a robust, multi-generational product pipeline. Its global intellectual property portfolio is substantial, encompassing 42 granted or allowed patents and an additional 23 patent applications currently under review. The company also benefits from a strategic collaboration agreement with Stryker Corporation, focusing on joint technology development.

MBOT (Microbot Medical Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $70.6M, a beta of 1.05 versus the broader market, a 52-week range of 1.45-4.67, average daily share volume of 1.2M, a public-listing history dating back to 1992, approximately 43 full-time employees. These structural characteristics shape how MBOT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.05 places MBOT roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a long call on MBOT?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

MBOT snapshot

As of August 14, 2026, spot at $1.52, ATM IV 36.60%, IV rank 4.75%, expected move 10.49%. The long call on MBOT below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this long call structure on MBOT specifically: MBOT IV at 36.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a MBOT long call, with a market-implied 1-standard-deviation move of approximately 10.49% (roughly $0.16 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MBOT expiries trade a higher absolute premium for lower per-day decay. Position sizing on MBOT should anchor to the underlying notional of $1.52 per share and to the trader's directional view on MBOT stock.

MBOT long call setup

The MBOT long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MBOT at $1.52 on that close, the first option leg uses a $1.52 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MBOT chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MBOT shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$1.52N/A

MBOT long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

MBOT long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on MBOT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on MBOT

Long calls on MBOT express a bullish thesis with defined risk; traders use them ahead of MBOT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

MBOT thesis for this long call

The market-implied 1-standard-deviation range for MBOT extends from approximately $1.36 on the downside to $1.68 on the upside. A MBOT long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current MBOT IV rank near 4.75% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MBOT at 36.60%. As a Healthcare name, MBOT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MBOT-specific events.

MBOT long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MBOT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MBOT alongside the broader basket even when MBOT-specific fundamentals are unchanged. Long-premium structures like a long call on MBOT are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current MBOT chain quotes before placing a trade.

Frequently asked questions

What is a long call on MBOT?
A long call on MBOT is the long call strategy applied to MBOT (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With MBOT stock at $1.52 on the most recent close, the strikes shown on this page are snapped to the nearest listed MBOT chain strike and the premiums come straight from that session's bid/ask midpoint.
How are MBOT long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the MBOT long call priced from the end-of-day chain at a 30-day expiry (ATM IV 36.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a MBOT long call?
The breakeven for the MBOT long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The MBOT market-implied 1-standard-deviation expected move in the same options snapshot is approximately 10.49%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on MBOT?
Long calls on MBOT express a bullish thesis with defined risk; traders use them ahead of MBOT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current MBOT implied volatility affect this long call?
MBOT ATM IV is at 36.60% with IV rank near 4.75%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related MBOT analysis